Leptomeningeal carcinomatosis in relapsed non-seminoma testis: a 1-year complete remission with high-dose chemotherapy.
A 1-year complete remission could be achieved with high-dose systemic chemotherapy in a 33-year-old patient with relapsed germ cell tumor presenting with leptomeningeal carcinomatosis (LC). Although LC in general has a very poor prognosis for patients with chemosensitive malignancies, systemic chemotherapy should be considered.
Denissen
N H A M
NH
Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
van Spronsen
D J
DJ
Smilde
T J
TJ
De Mulder
P H M
PH
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002277:Carcinoma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000209:etiology; D012074:Remission Induction; D016879:Salvage Therapy; D013736:Testicular Neoplasms / Q000188:drug therapy*